Southern California Permanente Group — Los Angeles, California

Southern California Permanente Group is a clinical research site located in Los Angeles, California, United States 90034.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Southern California Permanente Group has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Limited-Stage Small Cell Lung Cancer, Inguinal Hernia, Premature Birth of Newborn.

Sponsors: Shanghai Henlius Biotech, Vanderbilt University Medical Center.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Southern California Permanente Group?

Southern California Permanente Group has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Southern California Permanente Group conducted?

Southern California Permanente Group has 2 clinical trials on record, with 1 currently active. Their work covers Limited-Stage Small Cell Lung Cancer, Inguinal Hernia, Premature Birth of Newborn.

Is Southern California Permanente Group accredited by Crixeo Health?

Southern California Permanente Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Southern California Permanente Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.